We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

August 19, 2022

Sprint: DTx in Mental Health: Partnerships with Pharma

Commentary
&
HealthXL Team & HealthXL Community

The HealthXL Sprint 2-part meeting series connects senior leaders across our community to solve the latest health challenges. In our most recent sprint we discussed DTx and pharma partnerships in mental health. In this blog we’ve pulled out the top takeaways from this series.

5 key recommendations for DTx and pharma partnerships in mental health.

To achieve progress, continuous stakeholder alignment and buy-in is necessary. A bottom-up approach could also help drive progress. When partnering with pharma, it requires a lot of work to have everyone involved aligned and on the same path, however, this is necessary to be successful. Internally, pharma companies are experiencing similar challenges, with digital teams struggling to focus on end-points or functions of the product that will align with individual team goals.

Reducing drop-out rates of users is key in the post-launch phase of a product. The user experience needs to be good and is excellent in most apps. The solution needs to be integrated with the care plan, and scripting as well as integrated with EHR. Compliance is much better when the clinician is driving the care plan and the DTx is the reward. Increasing compliance and medication adherence will increase Pharma industry interest.

From the outset, it is important to have a clear definition of what you are treating. These solutions need to be built with a particular problem and population in mind, including: what the unmet need is and what the end-point looks like. There needs to be a tangible overlap between pharma business goals and patient needs for the solution to be successful. The patient needs to be involved from the start, and as the end user, if it’s not bringing value to them, they won’t use it.

Digital Therapeutic (DTx) data capture is becoming more relevant and needs to be built in from the start. Identifying key metrics and end-points will enable gathering of high quality data. Clearly providing a clinical outcome and solving an unmet need, could be the differentiating factor from a clinical and patient perspective and be used to build brand preference. DTx is becoming increasingly weighed for this, and will become more relevant including FDA approval.

Digital Health companies need to define the value they are creating for Pharma. It can be a challenge for Pharma to see the tangible value, and where the value is coming back to Pharma without the traditional model.  The revenue value for short-term and long-term needs to be evident. There are ROIs outside of profit and loss, however, it’s difficult to present these to Pharma. The limitations around additions of CPT codes and reimbursement will also create a challenge, with Pharma less familiar in this space. It is possible to take advantage of existing CPT codes outside of DTx, which may be an easier option compared to creating a new CPT code.


Experts Included: Anthony Como (Connected Care and Digital Health Solution Leader, Respiratory Care Business, Philips), Cathy Zaremba (Director of Product Marketing, BrightInsight), Christopher Hall (Vice President, Pharma, Mobio Interactive), Chrysonthia Horne (Senior Associate Investments & Venture Management, atai Life Sciences), Myles Furnace (Commercial VP, Closed Loop Medicine), Rani Cohen (Co-Founder, Gray Matters Health)

*All opinions are the participants’ own and do not necessarily reflect the stance of their respective employers.

Want to join the conversation? Check here for upcoming meetings and events.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: Key Considerations for Inclusion on the Evernorth Digital Health Formulary

13th December @ 10:45AM EDT

How do DTx products get listed on a formulary? And what happens next? Join this masterclass to hear from Mark Bini, the visionary who helped devise Evernorth's Digital Health Formulary.

Featuring
Mark Bini
Mark Bini
Chief Patient Experience Officer at Evernorth
Featuring
Mark Bini
Mark Bini
Chief Patient Experience Officer at Evernorth
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: Future EU Regulations for AI in Medical Devices

13th December @ 10AM GMT / 6PM AWST

Are you trying to commercialize AI-based digital health solutions in the European Union (EU)? Would you like to learn practical steps on how to navigate the EU regulations for AI in medical devices? Join us in this masterclass led by Erik Vollebregt (Partner at Axon Lawyers) to deep dive into this topic.

Featuring
Erik Vollebregt
Erik Vollebregt
Partner, Axon Lawyers
Featuring
Erik Vollebregt
Erik Vollebregt
Partner, Axon Lawyers
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Innovative Distribution Strategies for DTx

14th December @ 10:45 AM EDT

Currently, there is no one-size-fits-all strategy for DTx distribution. Join HealthXL in this meeting to discuss this topic further with your peers working in this space.

Featuring
Francesca Wuttke
Francesca Wuttke
CEO and Founder, nen Health
Featuring
Francesca Wuttke
Francesca Wuttke
CEO and Founder, nen Health
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: DTx Access Negotiation and Contracting with Commercial Health Plans in the US

15th December @ 10:45 AM EDT

Are you seeking reimbursement of a DTx solution in the US? Join this Masterclass led by Mike Pace to deep dive into this topic with your peers working in this space.

Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Telemedicine & Virtual Care Delivery
12th December @ 10:45AM EDT

Masterclass: Partnering with Health Systems in Digital Health

Are you working in digital health and looking for successful partnerships with health systems? Join this meeting to deep dive into this topic with other senior leaders in this field.

Michael Freni
Featuring
Michael Freni
Vice President, Business Development, Innovation & Venture Partner, A.I. Digital Innovation Fund, Mass General Brigham
Digital Therapeutics (DTx)
13th December @ 10:45AM EDT

Masterclass: Key Considerations for Inclusion on the Evernorth Digital Health Formulary

How do DTx products get listed on a formulary? And what happens next? Join this masterclass to hear from Mark Bini, the visionary who helped devise Evernorth's Digital Health Formulary.

Mark Bini
Featuring
Mark Bini
Chief Patient Experience Officer at Evernorth
Digital Therapeutics (DTx)
13th December @ 10AM GMT / 6PM AWST

Masterclass: Future EU Regulations for AI in Medical Devices

Are you trying to commercialize AI-based digital health solutions in the European Union (EU)? Would you like to learn practical steps on how to navigate the EU regulations for AI in medical devices? Join us in this masterclass led by Erik Vollebregt (Partner at Axon Lawyers) to deep dive into this topic.

Erik Vollebregt
Featuring
Erik Vollebregt
Partner, Axon Lawyers
Digital Therapeutics (DTx)
14th December @ 10:45 AM EDT

Innovative Distribution Strategies for DTx

Currently, there is no one-size-fits-all strategy for DTx distribution. Join HealthXL in this meeting to discuss this topic further with your peers working in this space.

Francesca Wuttke
Featuring
Francesca Wuttke
CEO and Founder, nen Health

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.